The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADESTO TECHNOLOGIES CORP. | COM | 00687D101 | 17,438 | 2,051,511 | SH | SOLE | 0 | 0 | 2,051,511 | ||
CHIASMA INC | COM | 16706W102 | 5,936 | 1,196,776 | SH | SOLE | 0 | 0 | 1,196,776 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 5,587 | 406,307 | SH | SOLE | 0 | 0 | 406,307 | ||
RUBIUS THERAPEUTICS INC | COM | 78116T103 | 24,874 | 2,618,351 | SH | SOLE | 0 | 0 | 2,618,351 | ||
SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 22,898 | 3,313,817 | SH | SOLE | 0 | 0 | 3,313,817 |